Redox dysregulation affects the ventral but not dorsal hippocampus: Impairment of parvalbumin neurons, gamma oscillations, and related behaviors

Journal of Neuroscience

Volumn 30, Issue 7, 2010, Pages 2547-2558

  Steullet, Pascal ^a   Cabungcal, Jan Harry ^a   Kulak, Anita ^a   Kraftsik, Rudolf ^b   Chen, Ying ^c   Dalton, Timothy P ^d   Cuenod, Michel ^a   Do, Kim Q ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KAINIC ACID; PARVALBUMIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DENTATE GYRUS; GLUTATHIONE METABOLISM; HIPPOCAMPUS; INTERNEURON; MALE; MOUSE; NERVE CELL; NONHUMAN; OSCILLATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; SCHIZOPHRENIA; SPATIAL MEMORY;

ADAPTATION, OCULAR; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BIOLOGICAL CLOCKS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CONDITIONING, CLASSICAL; DEOXYGUANOSINE; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; EXCITATORY AMINO ACID AGONISTS; EXPLORATORY BEHAVIOR; FEAR; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; HIPPOCAMPUS; INTERNEURONS; KAINIC ACID; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURAL PATHWAYS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PARVALBUMINS; PATTERN RECOGNITION, VISUAL; REWARD; SPATIAL BEHAVIOR;

EID: 77249141031     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3857-09.2010     Document Type: Article

References (66)

1. Abekawa T, Ito K, Nakagawa S, Koyama T (2007) Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats. Psychopharmacology (Berl) 192:303-316.
2. Bannerman DM, Rawlins JN, McHugh SB, Deacon RM, Yee BK, Bast T, Zhang WN, Pothuizen HH, Feldon J (2004) Regional dissociations within the hippocampus-memory and anxiety. Neurosci Biobehav Rev 28:273-283.
3. Bartos M, Vida I, Jonas P (2007) Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci 8:45-56.
4. Bast T, Zhang WN, Feldon J (2001a) Hyperactivity, decreased startle reactivity, and disrupted prepulse inhibition following disinhibition of the rat ventral hippocampus by the GABA(A) receptor antagonist picrotoxin. Psychopharmacology (Berl) 156:225-233.
5. Bast T, Zhang WN, Feldon J (2001b) The ventral hippocampus and fear conditioning in rats. Different anterograde amnesias of fear after tetrodotoxin inactivation and infusion of the GABA(A) agonist muscimol. Exp Brain Res 139:39-52.
6. Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, Dugan LL (2007) Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318:1645-1647.
7. Behrens MM, Ali SS, Dugan LL (2008) Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci 28:13957-13966.
8. Benes FM, Lim B, Matzilevich D, Walsh JP, Subburaju S, Minns M (2007) Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc Natl Acad Sci U S A 104:10164-10169.
9. Bjarkam CR, Sorensen JC, Geneser FA (2003) Distribution and morphology of serotonin-immunoreactive axons in the hippocampal region of the New Zealand white rabbit. I. Area dentata and hippocampus. Hippocampus 13:21-37.
10. Broadbent NJ, Squire LR, Clark RE (2004) Spatial memory, recognition memory, and the hippocampus. Proc Natl Acad Sci U S A 101:14515-14520.
11. Cabungcal JH, Nicolas D, Kraftsik R, Cuenod M, Do KQ, Hornung JP (2006) Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: relevance to schizophrenia. Neurobiol Dis 22:624-637.
12. Cadet JL, Brannock C (1998) Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 32:117-131.
13. Cho RY, Konecky RO, Carter CS (2006) Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci U S A 103:19878-19883.
14. 2+ modulation of the NMDA receptor. J Neurosci 21:392-400.
15. Cowell RM, Blake KR, Russell JW (2007) Localization of the transcriptional coactivator PGC-1alpha to GABAergic neurons during maturation of the rat brain. J Comp Neurol 502:1-18.
16. Dell'Anna E, Geloso MC, Magarelli M, Molinari M (1996) Development of GABA and calcium binding proteins immunoreactivity in the rat hippocampus following neonatal anoxia. Neurosci Lett 211:93-96.
17. Do KQ, Trabesinger AH, Kirsten-Kruger M, Lauer CJ, Dydak D, Hell D, Holsboer F, Boesiger P, Cuenod M (2000) Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 12:3721-3728.
18. Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M (2009a) Redox dysregulation, neurodevelopment and schizophrenia. Curr Opin Neurobiol 19:220-230.
19. Do KQ, Bovet P, Cabungcal JH, Conus P, Gysin R, Lavoie S, Steullet P, Cuenod M (2009b) Redox dysregulation in schizophrenia: genetic susceptibility and pathophysiological mechanisms. In: Handbook of neurochemistry and molecular neurobiology: schizophrenia, Vol 27, Ed 3, (Javitt DC, Kantrowitz JT, Lajtha A, eds), pp 285-311. New York: Springer.
20. Dugan LL, Ali SS, Shekhtman G, Roberts AJ, Lucero J, Quick KL, Behrens MM (2009) Il-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairment in aged mice through activation of neuronal NADPH oxidase. PloS One 4:e5518.
21. Esclassan F, Coutureau E, Di SG, Marchand AR (2009) Differential contribution of dorsal and ventral hippocampus to trace and delay fear conditioning. Hippocampus 19:33-44.
22. Fisahn A, Neddens J, Yan L, Buonanno A (2009) Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia. Cereb Cortex 19:612-618.
23. Fries P, Nikolic D, Singer W (2007) The gamma cycle. Trends Neurosci 30:309-316.
24. Fuchs EC, Zivkovic AR, Cunningham MO, Middleton S, Lebeau FE, Bannerman DM, Rozov A, Whittington MA, Traub RD, Rawlins JN, Monyer H (2007) Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron 53:591-604.
25. Gasbarri A, Sulli A, Packard MG (1997) The dopaminergic mesencephalic projections to the hippocampal formation in the rat. Prog Neuropsychopharmacol Biol Psychiatry 21:1-22.
26. Gaskin S, Gamliel A, Tardif M, Cole E, Mumby DG (2009) Incidental (unreinforced) and reinforced spatial learning in rats with ventral and dorsal lesions of hippocampus. Behav Brain Res 202:64-70.
27. Goldman MB, Mitchell CP (2004) What is the functional significance of hippocampal pathology in schizophrenia? Schizophr Bull 30:367-392.
28. Gysin R, Kraftsik R, Sandell J, Bovet P, Chappuis C, Conus P, Deppen P, Preisig M, Ruiz V, Steullet P, Tosic M, Werge T, Cuénod M, Do KQ (2007) Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc Natl Acad Sci U S A 104:16621-16626.
29. Harte MK, Powell SB, Swerdlow NR, Geyer MA, Reynolds GP (2007) Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats. J Neural Transm 114:893-898.
30. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA (2003) Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 23:6315-6326.
31. Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, Kong S, Wu D, Xue R, Andradé M, Tankou S, Mori S, Gallagher M, Ishizuka K, Pletnikov M, Kida S, Sawa A (2007) Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci U S A 104:14501-14506.
32. Hirrlinger J, Schulz JB, Dringen R (2002) Effects of dopamine on the glutathione metabolism of cultured astroglial cells: implications for Parkinson's disease. J Neurochem 82:458-467.
33. Hunsaker MR, Kesner RP (2008) Dissociations across the dorsal-ventral axis of CA3 and CA1 for encoding and retrieval of contextual and auditory-cued fear. Neurobiol Learn Mem 89:61-69.
34. Jaaro-Peled H, Hayashi-Takagi A, Seshadri S, Kamiya A, Brandon NJ, Sawa A (2009) Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends Neurosci 32:485-495.
35. Jessen F, Scheef L, Germeshausen L, Tawo Y, Kockler M, Kuhn KU, Maier W, Schild HH, Heun R (2003) Reduced hippocampal activation during encoding and recognition of words in schizophrenia patients. Am J Psychiatry 160:1305-1312.
36. Jiang M, Swann JW (2005) A role for L-type calcium channels in the maturation of parvalbumin-containing hippocampal interneurons. Neuroscience 135:839-850.
37. Kasai H (1997) Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 387:147-163.
38. Kinney JW, Davis CN, Tabarean I, Conti B, Bartfai T, Behrens MM (2006) A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci 26:1604-1615.
39. Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312-324.
40. Lodge DJ, Behrens MM, Grace AA (2009) A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci 29:2344-2354.
41. Maimone D, Cioni C, Rosa S, Macchia G, Aloisi F, Annunziata P (1993) Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1 beta and TNF alpha. J Neuroimmunol 47:73-81.
42. McHugh SB, Niewoehner B, Rawlins JN, Bannerman DM (2008) Dorsal hippocampal N-methyl-D-aspartate receptors underlie spatial working memory performance during non-matching to place testing on the T-maze. Behav Brain Res 186:41-47.
43. Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J (2008) Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 22:469-486.
44. Moudy AM, Kunkel DD, Schwartzkroin PA (1993) Development of dopamine-beta-hydroxylase-positive fiber innervation of the rat hippocampus. Synapse 15:307-318.
45. Oleskevich S, Descarries L, Lacaille JC (1989) Quantified distribution of the noradrenaline innervation in the hippocampus of adult rat. J Neurosci 9:3803-3815.
46. Ongur D, Cullen TJ, Wolf DH, Rohan M, Barreira P, Zalesak M, Heckers S (2006) The neural basis of relational memory deficits in schizophrenia. Arch Gen Psychiatry 63:356-365.
47. Penschuck S, Flagstad P, Didriksen M, Leist M, Michael-Titus AT (2006) Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia. Eur J Neurosci 23:279-284.
48. Rabinovic AD, Hastings TG (1998) Role of endogenous glutathione in the oxidation of dopamine. J Neurochem 71:2071-2078.
49. Schmitz C, Hof PR (2005) Design-based stereology in neuroscience. Neuroscience 130:813-831.
50. Shen S, Lang B, Nakamoto C, Zhang F, Pu J, Kuan SL, Chatzi C, He S, Mackie I, Brandon NJ, Marquis KL, Day M, Hurko O, McCaig CD, Riedel G, St Clair D (2008) Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. J Neurosci 28:10893-10904.
51. Sohal VS, Zhang F, Yizhar O, Deisseroth K (2009) Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459:698-702.
52. Steullet P, Neijt HC, Cuenod M, Do KQ (2006) Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia. Neuroscience 137:807-819.
53. Steullet P, Lavoie S, Kraftsik R, Guidi R, Gysin R, Cuenod M, Do KQ (2008) A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons. Free Radic Biol Med 44:1042-1054.
54. Tosic M, Ott J, Barral S, Bovet P, Deppen P, Gheorghita F, Matthey ML, Parnas J, Preisig M, Saraga M, Solida A, Timm S, Wang AG, Werge T, Cuénod M, Do KQ (2006) Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am J Hum Genet 79:586-592.
55. Traub RD, Bibbig A, Lebeau FE, Buhl EH, Whittington MA (2004) Cellular mechanisms of neuronal population oscillations in the hippocampus in vitro. Annu Rev Neurosci 27:247-278.
56. Tseng KY, Lewis BL, Hashimoto T, Sesack SR, Kloc M, Lewis DA, O'Donnell P (2008) A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons. J Neurosci 28:12691-12699.
57. Uhlhaas PJ, Haenschel C, Nikolic D, Singer W (2008) The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia. Schizophr Bull 34:927-943.
58. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44-84.
59. Vreugdenhil M, Jefferys JG, Celio MR, Schwaller B (2003) Parvalbumin-deficiency facilitates repetitive IPSCs and gamma oscillations in the hippocampus. J Neurophysiol 89:1414-1422.
60. Wang CZ, Yang SF, Xia Y, Johnson KM (2008) Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons. Neuropsychopharmacology 33:2442-2455.
61. West MJ (1999) Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci 22:51-61.
62. West MJ (2002) Design-based stereological methods for counting neurons. Prog Brain Res 35:43-51.
63. West MJ, Slomianka L, Gundersen HJ (1991) Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using optical fractionator. Anat Rec 231:482-497.
64. Yang Y, Dieter MZ, Chen Y, Shertzer HG, Nebert DW, Dalton TP (2002) Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response. J Biol Chem 277:49446-49452.
65. Zhang Y, Behrens MM, Lisman JE (2008) Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex. J Neurophysiol 100:959-965.
66. Zhang ZJ, Reynolds GP (2002) A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res 55:1-10.